| Serial Number | 79288213 |
| Word Mark | CURIGIN |
| Filing Date | Tuesday, April 21, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 14, 2021 |
| Registration Number | 6585328 |
| Registration Date | Tuesday, December 14, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 28, 2021 |
| Goods and Services | Biopharmaceuticals for the prevention of cancer; biopharmaceuticals for the diagnosis of cancer; biopharmaceuticals for the treatment of cancer; biopharmaceuticals in the form of cancer oncolytic virus for the prevention of cancer; biopharmaceuticals in the form oncolytic virus for the diagnosis of cancer; biopharmaceuticals in the form of oncolytic virus for the treatment of cancer; Drugs for medical purpose for the treatment of cancer and non-cancerous diseases, namely, respiratory, metabolic, neurological, ophthalmological, gastrointestinal, cardiovascular, skin, urogenital, gynecological, endocrine, head and neck, skeletal, autoimmune and rare diseases; Veterinary preparations for the treatment of cancer and non-cancerous diseases, namely, respiratory, metabolic, neurological, ophthalmological, gastrointestinal, cardiovascular, skin, urogenital, gynecological, endocrine, head and neck, skeletal, autoimmune and rare diseases; anti-cancer preparations; antiulcerants; vaccines; pharmaceutical preparations and substances for the prevention of cancer; viral and non-viral vector-based pharmaceutical products for the treatment of cancer; viral and non-viral vector-based pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical compounds for treating cancer; pharmaceuticals for viral and non-viral vector-based gene therapy; medicine for viral and non-viral vector-based gene therapy for human purposes; antibiotics; dietary supplements; dietetic nutritionally fortified food adapted for medical purposes; insecticides; fungicides |
| Goods and Services | Providing commercial information and consumer product information; import-export agency services; sales agency services, namely, sales promotion for others in the field of apparatus for use in medical analysis; arranging sales events for others in the field of apparatus for use in medical analysis; sales agency services, namely, sales promotion for others in the field of pharmaceuticals; arranging sales events for others in the field of pharmaceuticals; business intermediary services in the nature of purchasing pharmaceuticals for others relating to mail order by telecommunications; procurement of contracts for the purchase and sale of goods and services; advertising services; advertising services relating to pharmaceutical products; business intermediary services in the nature of matching purchasers with sellers of goods and services for the sale and purchase of goods and services |
| Goods and Services | Providing health information, not including dentistry; healthcare information services relating to the use of medical products for the prevention, diagnosis and treatment of cancer and non-cancerous diseases; medical and pharmaceutical consultancy; consultancy services relating to pharmaceutical products for the prevention, diagnosis and treatment of cancer and non-cancerous diseases; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products for the prevention, diagnosis and treatment of cancer and non-cancerous diseases |
| Goods and Services | Research relating to biotechnology; scientific research for medical purposes in the field of cancerous diseases; research relating to pharmaceuticals; research in the field of medical products; medical research services; conducting clinical trials for others; clinical studies in the nature of medical research; development of new technology for others in the field of biotechnology; scientific research for medical purposes in the area of cancerous diseases; development of medical products; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; conducting clinical research in the field of medicines; clinical trials of medicines, for others; software design and development; computer programming for others in the medical field |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 26, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 26, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 26, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 26, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Curigin Co., Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Curigin Co., Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Curigin Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Wednesday, May 25, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, May 24, 2022 | FINAL DISPOSITION PROCESSED |
| Monday, March 14, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Sunday, December 19, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, December 14, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, December 1, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 1, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, October 25, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, September 28, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 28, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 22, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 22, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 8, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 25, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 25, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, August 25, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 25, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 25, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 9, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 9, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, April 8, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, April 8, 2021 | FINAL REFUSAL E-MAILED |
| Thursday, April 8, 2021 | FINAL REFUSAL WRITTEN |
| Thursday, February 25, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 25, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 25, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, September 27, 2020 | REFUSAL PROCESSED BY IB |
| Saturday, September 5, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, August 25, 2020 | REFUSAL PROCESSED BY MPU |
| Sunday, July 19, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, July 18, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, July 13, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, June 30, 2020 | APPLICATION FILING RECEIPT MAILED |
| Friday, June 26, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, June 25, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |